The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of adjuvant chemotherapy for pT2-4 upper urinary tract urothelial cancer: Exploratory analysis of large multi-institutional study (JCOG1110A).
 
Junichi Inokuchi
No Relationships to Disclose
 
Kentaro Kuroiwa
No Relationships to Disclose
 
Hiroyuki Nishiyama
Consulting or Advisory Role - Bayer Yakuhin; Chugai Pharma; Janssen; Lilly; MSD
Speakers' Bureau - Chugai Pharma; MSD
Research Funding - Astellas Pharma (Inst); Ono Pharmaceutical (Inst); Takeda (Inst)
 
Takahiro Kojima
No Relationships to Disclose
 
Yoshiyuki Kakehi
No Relationships to Disclose
 
Mikio Sugimoto
No Relationships to Disclose
 
Toshiki Tanikawa
No Relationships to Disclose
 
Hiroyuki Fujimoto
No Relationships to Disclose
 
Momokazu Gotoh
No Relationships to Disclose
 
Naoya Masumori
Honoraria - Janssen; Kissei Pharmaceutical; Kyorin; Nippon Shinyaku; Takeda
Consulting or Advisory Role - Vorpal Technology
Research Funding - Astellas Pharma; Daiichi Sankyo; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Osamu Ogawa
No Relationships to Disclose
 
Masatoshi Eto
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Eisai; Novartis; Ono Pharmaceutical; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Kissei Pharmaceutical; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
Research Funding - ASKA Pharmaceutical; Astellas Pharma; Bayer; Chugai Pharma; Daiichi Sankyo; Kissei Pharmaceutical; Lilly; Nihon Medi-Physics; Nippon Kayaku; Nippon Shinyaku; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
 
Chikara Ohyama
Travel, Accommodations, Expenses - Astellas Pharma; Janssen
 
Akito Yamaguchi
No Relationships to Disclose
 
Hideyasu Matsuyama
Honoraria - AstraZeneca; Bayer; Bayer; Janssen; MSD; Sanofi
Consulting or Advisory Role - Janssen; Sanofi
Research Funding - Janssen (Inst)
 
Tomohiko Ichikawa
No Relationships to Disclose
 
Keiichi Ito
No Relationships to Disclose
 
Junki Mizusawa
No Relationships to Disclose
 
Junko Eba
No Relationships to Disclose
 
Seiji Naito
No Relationships to Disclose